Theravance Biopharma (TBPH) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Theravance Biopharma (TBPH) over the last 13 years, with Q3 2025 value amounting to -$25.4 million.
- Theravance Biopharma's Other Gross PP&E Adjustments rose 1324.06% to -$25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.4 million, marking a year-over-year increase of 1324.06%. This contributed to the annual value of $1.5 million for FY2024, which is 11615.57% up from last year.
- According to the latest figures from Q3 2025, Theravance Biopharma's Other Gross PP&E Adjustments is -$25.4 million, which was up 1324.06% from -$26.5 million recorded in Q2 2025.
- In the past 5 years, Theravance Biopharma's Other Gross PP&E Adjustments registered a high of $12.5 million during Q4 2021, and its lowest value of -$42.5 million during Q1 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$35.4 million (2024), whereas its average is -$28.0 million.
- Per our database at Business Quant, Theravance Biopharma's Other Gross PP&E Adjustments soared by 19577.95% in 2021 and then crashed by 325958.19% in 2023.
- Over the past 5 years, Theravance Biopharma's Other Gross PP&E Adjustments (Quarter) stood at $12.5 million in 2021, then crashed by 97.7% to $287000.0 in 2022, then tumbled by 3259.58% to -$9.1 million in 2023, then surged by 116.16% to $1.5 million in 2024, then tumbled by 1837.2% to -$25.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$25.4 million for Q3 2025, versus -$26.5 million for Q2 2025 and -$27.4 million for Q1 2025.